Greg Freiherr, Industry Consultant
Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | Radiology Imaging| November 09, 2016

How Radiology Can Improve Outcomes and Make Medicine Better

radiology outcomes

Graphic courtesy of Pixabay

Much has been said about the potential of outcomes to change the practice of medicine. Through comparative studies, outcomes research could point out how, under certain circumstances, the use of one imaging technology might be better than others. It might simplify the choice and process by which referring physicians order exams, encouraging best practices not only in the choice of a modality but in the use of specific scan protocols.

Increased efficiency might result, leading to the better use of personnel and reduced financial costs. Effective treatment might start sooner, resulting in clinical, financial and operational benefits. Reimbursement might be increased for procedures that boost efficiency, reduce overall cost or improve patient care. This would reverse the decades-old trend of across-the-board cuts in reimbursement for imaging. Supporting such a change might be, for example, a reduction in hospital readmission as an indicator of improved patient management — following early intervention made possible by a type of imaging.

This is all speculation, of course, based on the premise that outcomes research could identify impacts on the everyday care of patients. Reduced hospital readmission very likely will depend on multiple factors. At the very least, it will depend on practices and resources at individual hospitals.

 

Consider the Source

It makes sense, therefore, when planning an outcomes-based study, to first consider the strategic goals and initiatives of the hospitals in which the research will be conducted. Also important is the context established by hospital resources and staff. These will vary widely, for example, from a community hospital to a tertiary medical facility. They may vary even further if either is part of an integrated delivery network.

If conditions and resources are controlled, it may be possible to compare the relative value of modalities. But differences in staff training and varying capabilities of technology at different facilities could skew results when attempting to migrate findings.

What may be less susceptible — and could yield more immediate results, as well as be more effective at individual facilities — will be studies that use the institution as its own control. Efficiency would be the cornerstone of such efforts.

Increased efficiency might be achieved through the elimination of duplicative or ineffective services. Doing so might speed certain patients through the healthcare system, improving health as well as yielding financial savings. Doing so would achieve the goal of value-based medicine — improved healthcare at a reduced cost, albeit on a modest and local scale. It would, however, have the added benefit of improving patient satisfaction, which institutions are increasingly paying attention.

 

Patient Satisfaction

I like it when the guy stocking shelves nods to me as I walk the aisle of a grocery store and when the electronics clerk walks me to housewares to find what I can’t. But in healthcare … come on. If I’m a patient, I want the staff to make me feel better fast. Sure, be friendly. But don’t apply a social salve when I need relief from a physical ailment.

What radiology can do toward that end is what radiology is uniquely positioned to do. Take, for example, a widely used protocol to work up diabetics suspected of a bone infection. This infection, called osteomyelitis, often requires surgery. Diabetics are particularly susceptible.

Those showing signs of the infection may go through a process that ratchets up from less to more invasive and effort-intensive technologies. Radiography may be followed by MRI, then SPECT using white blood cells drawn from the patient and radiolabeled with a gamma-emitting isotope. This three-step process can take up to six days. Going directly from radiography to SPECT/CT — and eliminating MRI, which can add uncertainty as well as expense and time — streamlines the process by thousands of dollars and two, or even three days.

Because patients are typically hospitalized during this diagnostic process, collapsing the process shifts care from inpatient to outpatient. This saves money, as it improves care and, ultimately, increases patient satisfaction.

This is just one example of how improving outcomes for patients can bring healthcare closer to the ideals of value-based medicine. And how radiology can play a key role. There are almost certainly others waiting to be uncovered.

As practiced today, routine care is inefficient, quality is variable, and expenses are high. Finding ways to bring these in line is the key to value-based healthcare. We might find these ways if radiology can peel back the layers of medical practice by leveraging the unique technologies that are already at its disposal.

 

Editor's note: This is the second blog in a four-part series on Changing the Look of Radiology. The first blog, "Risk Abatement May Determine the Future of Radiology" can be found here. The series can be found here.

Related Content

Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
Charles Ananian, M.D.

Charles Ananian, M.D.

Sponsored Content | Case Study | Digital Radiography (DR) | November 07, 2018
Whether it’s a premature baby or a critically ill child, treating little patients is a huge responsibility.
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Sponsored Content | Case Study | Computed Tomography (CT) | November 06, 2018
The following is a summary of a study published in the
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.